The Association for Molecular Pathology , the premier global, non-profit molecular diagnostics professional society, today published guideline recommendations for both clinical laboratory professionals and oncologists that assess the status of next-generation sequencing -based cancer tests and establish standardized classification, annotation, interpretation, and reporting conventions for somatic sequence variants. The new guideline was developed by a Working Group comprised of representatives from major professional associations whose members provide professional testing and treatment services to cancer patients.